PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 9117042

Interventions for fatigue.

C H Yarbro
View original source ↗Export metadata ↓

Abstract

Fatigue is the most frequently reported symptom of cancer and cancer treatment, which can significantly impair the patient's quality of life. It may also interfere with cancer therapy compliance and even limit the amount of treatment that a patient receives. There is little information on, and research into, the mechanisms of fatigue and the relationships between its multiple causes, patterns and the many factors that may improve or worsen the condition. The management of fatigue, therefore, represents a major nursing challenge. The nurse's role in combating cancer-related fatigue spans the treatment continuum from prevention to research. It includes: patient assessment to identify those at high risk and to evaluate potential causes of fatigue; and the implementation of interventions to manage the fatigue, such as patient and family education, self-care activities and treatment of specific problems. Continued research on the multiple aspects of cancer-related fatigue, together with multifaceted projects such as the fatigue initiative, will lead to improved oncology nursing care of patients with cancer-related fatigue.

Explore related subjects

FatigueHumansNeoplasmsNursing AssessmentOncology NursingPatient Education as TopicQuality of LifeSelf CareJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C H Yarbro. 1996. Interventions for fatigue.. https://doi.org/10.1111/j.1365-2354.1996.tb00250.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2002

Treatment of fatigue in fibromyalgia.

Clearly, fatigue is a large and challenging problem for those suffering from fibromyalgia. It adds greatly to the morbidity and disability associated with the disease. In the management of this specific symptom in fibromyalgia, attention should first be focused on identifying comorbidities that may be present and contribute to fatigue. As with other symptoms of fibromyalgia, education is a critical component of management. This can be done by the practitioner, with available free resources, or with specialized cognitive behavioral programs. This education process can be augmented with a variety of other nonpharmacologic therapies, especially very gradually increasing, low-impact, aerobic exercise programs. Numerous pharmacologic therapies may also be helpful as an adjunct to treatment. Classes of compounds that raise central levels of norepinephrine or dopamine appear to be the most specific for management of fatigue. There are also many medications used to combat fatigue in other disorders that have not yet been adequately explored as to the possible benefits in alleviating the fatigue of fibromyalgia. Advances in the management of fatigue in fibromyalgia are likely to come from a variety of directions. Easier access to well designed nonpharmacologic therapies is essential, because these treatments are underutilized in clinical practice at present. Improvements in pharmacologic therapies will come from new insights into mechanisms, especially those that might only be present in subsets of patients and would respond to more targeted therapies.

Fatigue↗
PubMed2002

Rational and targeted pharmacologic treatment of fibromyalgia.

Despite disappointing results when subjected to randomized clinical trials, pharmacologic agents remain an important component of FM management. Addressing the main symptoms of pain, disturbed sleep, mood disturbances, fatigue, and associated conditions is essential to improve patient functioning and enhanced quality of life. However, much work remains to design clinical trials which address the complexity of FM, while satisfying evidence based medicine paradigms.

Fatigue↗
PubMed2002

Opioids, sleep, and cancer-related fatigue.

Oddly enough, little is known about the effects on sleep of commonly administered analgesic medications. Even less is known about their effect on next-day fatigue, mood, and cognitive functioning. We speculate that part of the fatigue typically experienced by cancer patients can be attributed to disruption of sleep by opioid medications they are taking. Fatigue and sleep are critical to the quality of life of cancer patients. Research is needed to assess the sleep and next-day consequences that can be expected from typical doses of different types of pain medications.

Fatigue↗